Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $89,802.06 +0.02%
Ethereum $2,960.06 -1.61%
BNB $890.28 +0.04%
Optimism $0.31 -1.70%
Arbitrum $0.18 -3.80%
Solana $128.52 -0.96%
Polygon $0.22 +2.77%
Cosmos $2.39 -0.64%
Avalanche $12.24 -1.84%

Bitcoin $89,802.06 +0.02%
Ethereum $2,960.06 -1.61%
BNB $890.28 +0.04%
Optimism $0.31 -1.70%
Arbitrum $0.18 -3.80%
Solana $128.52 -0.96%
Polygon $0.22 +2.77%
Cosmos $2.39 -0.64%
Avalanche $12.24 -1.84%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B